In 2004, Jiang’s group revealed that BBR increased the expression of the LDLR gene at the post-transcriptional level via stabilizing LDLR mRNA, proposing one of the main mechanisms to explain the anti-hyperlipidemia effects of BBR5. This evidence concerns the gene LDLR and hyperlipidemia.